StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

Investment analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Shares of NASDAQ CALA opened at $0.00 on Thursday. Calithera Biosciences has a fifty-two week […]